Jeffrey L. Wade
2013
In 2013, Jeffrey L. Wade earned a total compensation of $973.6K as Executive Vice President, Corporate and Administrative Affairs and Chief Financial Officer at Lexicon Pharmaceuticals, a 8% decrease compared to previous year.
Compensation breakdown
| Option Awards | $432,915 |
|---|---|
| Salary | $391,667 |
| Stock Awards | $142,120 |
| Other | $6,938 |
| Total | $973,640 |
Wade received $432.9K in option awards, accounting for 44% of the total pay in 2013.
Wade also received $391.7K in salary, $142.1K in stock awards and $6.9K in other compensation.
Rankings
In 2013, Jeffrey L. Wade's compensation ranked 6,737th out of 12,286 executives tracked by ExecPay. In other words, Wade earned more than 45.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,737 out of 12,286 | 45th |
Division Manufacturing | 2,377 out of 4,612 | 49th |
Major group Chemicals And Allied Products | 714 out of 1,462 | 51st |
Industry group Drugs | 523 out of 1,156 | 55th |
Industry Pharmaceutical Preparations | 415 out of 890 | 53rd |
Source: SEC filing on March 18, 2016.
Wade's colleagues
We found four more compensation records of executives who worked with Jeffrey L. Wade at Lexicon Pharmaceuticals in 2013.
2013
Arthur Sands
Lexicon Pharmaceuticals
Chief Executive Officer
2013
Brian Zambrowicz
Lexicon Pharmaceuticals
Chief Scientific Officer
2013
Pablo Lapuerta
Lexicon Pharmaceuticals
Chief Medical Officer
2013
Alan Main
Lexicon Pharmaceuticals
Executive Vice President, CMC and Supply Operations
News
Lexicon Pharmaceuticals CEO Lonnel Coats' 2023 pay slips 1% to $4.1M
March 26, 2024
Lexicon Pharmaceuticals CEO Lonnel Coats' 2021 pay rises 2% to $3.9M
April 8, 2022
Lexicon Pharmaceuticals CEO Lonnel Coats' 2020 pay stays at $3.9M
March 19, 2021
Lexicon Pharmaceuticals CEO Lonnel Coats' 2019 pay jumps 24% to $3.9M
March 13, 2020
Lexicon Pharmaceuticals CEO Lonnel Coats' 2018 pay jumps 41% to $3.1M
March 14, 2019